Article citationsMore>>

Li, Y. (2022). China’s Corporate Social Responsibility Fulfillment Is Changing from Passive to Active|Interpretation of the “2022 China Corporate Social Responsibility Research Report: The Power of Endogeneity” (Part 1). Yicai.
https://www.yicai.com/news/101647239.html

has been cited by the following article:

• TITLE: Establishment of Corporate Social Responsibility Evaluation Index System of Chinese Pharmaceutical Distribution Enterprises —Based on Grounded Theory

  AUTHORS: Lili Liu, Yingyu Wu, Jue Gan

  KEYWORDS: Pharmaceutical Distribution Enterprises, Corporate Social Responsibility, Evaluation Structure Dimension Model, Evaluation Index, Grounded Theory

  JOURNAL NAME: Advances in Applied Sociology, Vol.13 No.4, April 20, 2023

  ABSTRACT: Chinese pharmaceutical distribution enterprises lack scientific, reasonable, and applicable evaluation indices of corporate social responsibility (CSR). To address this gap, this study took a qualitative research approach, involving in-depth interviews with 22 experts from the pharmaceutical distribution industry and intermediary evaluation agencies, based on grounded theory. Data analysis was conducted in three levels of coding using Nvivo12 software. The research adopted inductive and deductive reasoning to construct a hierarchy model to evaluate the social responsibility of pharmaceutical distribution enterprises in China. This model is a three-level evaluation index system with 7 primary indicators such as corporate responsibility governance, 14 secondary indicators such as employment, and 62 tertiary indicators such as responsible departments. This study provides a framework to accurately assess the development of CSR in Chinese pharmaceutical distribution enterprises and can serve as a guide for CSR construction within the industry.